FDA Advisers Recommend OTC Narcan, But With Usage Instructions

Members of two FDA advisory panels voted unanimously to recommend Emergent Biosolutions’ Narcan (naloxone) become the first opioid overdose reversal drug to be made available over the counter, though they also asked the manufacturer to make it more clear to users how the product should be administered. FDA is slated to decide on final approval of the OTC product by March 29. FDA’s Nonprescription Drugs Advisory Committee (NDAC) and Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) met in a...